CA
AVBP icon

Cliff Asness’s ArriVent BioPharma AVBP Stock Holding History

Cliff Asness’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Buy
21,517
+5,594
+35% +$165K ﹤0.01% 3175
2026
Q1 		$367K Buy
15,923
+4,448
+39% +$100K ﹤0.01% 3305
2025
Q4 		$231K Sell
11,475
-348
-3% -$7.24K ﹤0.01% 3296
2025
Q3 		$218K Sell
11,823
-2,513
-18% -$49.4K ﹤0.01% 3223
2025
Q2 		$312K Buy
+14,336
New +$298K ﹤0.01% 2856
2025
Q1 		– Sell
-8,868
Closed -$236K – 3209
2024
Q4 		$236K Buy
8,868
+211
+2% +$6.06K ﹤0.01% 2607
2024
Q3 		$203K Buy
+8,657
New +$197K ﹤0.01% 2562

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cliff Asness's AVBP Position: Q2 2026 in Review

Cliff Asness increased its ArriVent BioPharma (AVBP) stake by 35% in Q2 2026, buying an estimated $165K and bringing the position to 21,517 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Cliff Asness first reported a position in AVBP in Q3 2024 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Cliff Asness held 21,517 shares of ArriVent BioPharma worth $748K as of Q2 2026.
  • Cliff Asness bought 5,594 ArriVent BioPharma shares in Q2 2026, an estimated $165K.
  • ArriVent BioPharma made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3175 holding.
  • Cliff Asness first reported a position in ArriVent BioPharma in Q3 2024 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.